Back to
UBS Group AG
MENS4 quarters
Position history for
UBS Group AG's holdings in JYONG BIOTECH LTD
Yes. Ubs holds 4,046 shares of MENS (Jyong Biotech), worth $8,376, as of its Q2 2026 13F filing. It reduced the position by 33,317 shares (-89.2%) from Q1 2026. Ubs has held MENS since Q3 2025, across 4 quarterly 13F filings.
Current Value
$8,376
Current Shares
4,046
Total Value Change
-$12,771
Total Shares Change
+3,509
Quarter-by-Quarter History
Other major holders of MENS: GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., HRT FINANCIAL LP, CITADEL ADVISORS LLC